Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Lyka Labs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹76.60up ₹0.35 (0.46%)BSE ₹77.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹76.25.
30 Oct: open ₹77.77, high ₹77.77, low ₹76.60
52-week range of traded prices to 30 Oct 2026
₹44.10Low, 30 Mar 2026₹98.25High, 31 Oct 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹277 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,475
Lyka Labs board meetings
270 filed, newest first. Page 6 of 6.
Feb 2010
15 Feb · Board meeting
For : (1) Adoption of Audited Annual Accounts for the period of 18 months ended September 30, 2009. (2) Adoption of Audited Consolidated Annual Accounts for the period ended September 30, 2009 and (3) Taking on record the Consolidated Unaudited Financial Results for the Quarter ended December 31, 2009.
Jan 2010
18 Jan · Board meeting
Meeting on 30 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
22 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the sixth quarter ended September 30, 2009.
Jul 2009
20 Jul · Board meeting
Meeting on 31 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Apr 2009
20 Apr · Board meeting
Meeting on 29 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
Jan 2009
19 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
15 Oct · Board meeting
Meeting on 24 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Aug 2008
22 Aug · Board meeting
To consider Adoption of Account for the year ended March 31, 2008.13 Aug · Board meeting
To consider the Audited Annual Accounts for the year ended March 31, 2008.
Jul 2008
23 Jul · Board meeting
Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Apr 2008
17 Apr · Board meeting
Meeting on 30 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Jan 2008
22 Jan · Board meeting
Meeting on 31 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
31 Oct · Board meeting
To consider the issue of Financial Instruments on Preferential basis.24 Oct · Board meeting
Meeting on 31 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
23 Jul · Board meeting
Meeting on 31 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”13 Jul · Board meeting
To consider the Audited Accounts for the 18 months from October 01, 2005 to March 31, 2007 and to consider other business matters.
Jun 2007
20 Jun · Board meeting
At the meeting of the Board of Directors of the Company held this evening (June 19, 2007), it was decided that the Company will issue upto 10,00,000 Equity Shares to Business Associates/Domestic Body Corporates and Domestic Investors. The Board also decided to issue upto 3,00,000 Equity Share Warrants to Promoters / Business Associates. The pricing of the Equity Share / Warrants will be determined as per the Guidelines on Preferential issue dated 4th August, 1994 issued by SEBI (as amended up to date) and authorized the Chairman to take necessary steps in this behalf. An Extra Ordinary general meeting is being called to consider the passing of the Special resolution under Section 81(1A) of the Companies Act, 195612 Jun · Board meeting
Meeting of the Board of Directors of the Company will be held on June 19, 2007 to consider the issue of Financial Instruments on Preferential basis.
Apr 2007
18 Apr · Board meeting
Meeting on 30 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Jan 2007
23 Jan · Board meeting
Meeting on 31 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”